Publication | Closed Access

Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy

Radiation TherapyStage IibMedicineRadical TherapyCancer TreatmentOncologyRadiation OncologyLung CancerRadiologyHealth Sciences